Skip to main content
DuChemBio Co, LTD logo

DuChemBio Co, LTD — Investor Relations & Filings

Ticker · 176750 ISIN · KR7176750008 KO Manufacturing
Filings indexed 291 across all filing types
Latest filing 2023-09-01 Declaration of Voting R…
Country KR South Korea
Listing KO 176750

About DuChemBio Co, LTD

http://www.duchembio.com/en/

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company DuChemBio. It explicitly lists the resolutions passed, specifically the appointment of a new director (Kim Sang-woo). This falls under the category of Declaration of Voting Results, as it reports the outcome of shareholder voting at a general meeting.
2023-09-01 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It details the outgoing and incoming directors, the reason for the change (resignation and new appointment), the date of the board resolution, and the professional background of the new appointee. This fits the definition of a Board/Management Information filing.
2023-09-01 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for DuChemBio. It includes the meeting agenda, details on director nominations, and management information required for shareholder review prior to the meeting. This falls under the category of materials provided to shareholders for meeting information and voting purposes.
2023-08-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'DuChemBio'. It details the date, time, location, and the agenda items, specifically the appointment of a new director. This type of document is sent to shareholders to provide information and request votes for an upcoming meeting, which aligns with the definition of a Proxy Solicitation & Information Statement.
2023-07-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (임시주주총회). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action (setting a record date). Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2023-07-17 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) filed by DuChemBio. It contains detailed financial information, corporate history, capital structure, and management details for the fiscal year 2022. Although it is labeled as a 'correction' (정정신고), it constitutes the full annual report filing required by regulatory authorities. According to the definitions, a comprehensive yearly report covering company activity and financial performance is classified as a 10-K. FY 2022
2023-07-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.